Both medications were initially developed to treat type 2 diabetes, but clinical results showing dramatic weight reductions sparked their evolution into tools for obesity management
Psychiatry 36 JensenC
Semaglutide, the active ingredient in Ozempic and Wegovy, and tirzepatide, the active ingredient in Mounjaro and Zepbound, have shifted this paradigm
doi: 10.3390/nu13010062 [DOI] [PMC free article] [PubMed] [Google Scholar] 41.Gianmoena K Gasparoni N Jashari A, et al
Additionally, the degree of appetite reduction may plateau or diminish slightly over time as physiological adaptation occurs, though clinical efficacy generally persists with continued use
After a discounted first month of $45, the ongoing membership is $145 and covers provider check-ins, progress tracking, messaging access, and support services like an insurance concierge